TACLX
Price
$22.93
Change
+$0.01 (+0.04%)
Updated
Jul 13 closing price
Net Assets
327.83M
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

TACLX vs VFFSX

TACLX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
TACLX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TACLX is a Hold and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. TACLX (328M). VFFSX pays higher dividends than TACLX: VFFSX (1.08) vs TACLX (0.30). TACLX was incepted earlier than VFFSX: TACLX (12 years) vs VFFSX (10 years). TACLX (1.34) is less costly to investors than VFFSX (0.01). TACLX is a more actively managed with annual turnover of: 12.00 vs. VFFSX (2.00). TACLX has a lower initial minimum investment than VFFSX: TACLX (2500) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. TACLX (14.93). VFFSX return over 5 years is better than : 73.48 vs. TACLX (30.00).
TACLXVFFSXTACLX / VFFSX
Total Expense Ratio1.040.0110,400%
Annual Report Gross Expense Ratio1.340.0113,400%
Fund Existence12 years10 years-
Gain YTD12.62910.685118%
Front Load5%N/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets328M1.67T0%
Annual Yield % from dividends0.301.0828%
Returns for 1 year14.9321.0771%
Returns for 3 years35.2468.4551%
Returns for 5 years30.0073.4841%
Returns for 10 years125.95251.2150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6